Therapy for chronic pruritus-light at the end of a long tunnel?

Der Internist
Manuel P PereiraMartin Metz

Abstract

Chronic pruritus (CP) is a highly prevalent, difficult-to-treat, and burdensome condition. Today, multiple topical and systemic therapy concepts are available for the treatment of CP. Current guidelines recommend, besides topical treatments, the use of a vast array of mostly off-label systemic drugs with different mechanisms, including antihistamines, gabapentinoids, antidepressants, immunosuppressive drugs, and μ‑opioid receptor antagonists. The choice of the right agent depends on the indication, the safety profile of the drug, and patient-specific features, such as comorbidities and comedication. Thanks to a deeper understanding of the pathophysiology of CP, novel drugs have been developed and have already shown antipruritic efficacy in clinical studies and case reports. Of note, phosphodiesterase‑4 inhibitors as topical agents and monoclonal antibodies, neurokinin‑1 receptor antagonists, Janus kinase inhibitors, and opioid receptor modulators as systemic agents are in the frontline of innovative CP treatment. Other promising targets include structures of the peripheral and central nervous system which are involved in itch signaling. This article provides an overview of currently available topical and systemic therapies for ...Continue Reading

References

Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Björn WikströmYuji Ueno
Jun 23, 2006·Nature Reviews. Neuroscience·Akihiko IkomaMartin Schmelz
May 12, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S SchulzS Ständer
May 21, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·F MalekzadS Nasiri
Nov 21, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hiroo KumagaiHiromichi Suzuki
May 14, 2010·Journal of the American Academy of Dermatology·Ngoc Quan PhanSonja Ständer
Jul 20, 2011·Seminars in Cutaneous Medicine and Surgery·Sarina B Elmariah, Ethan A Lerner
Apr 17, 2012·Acta Dermato-venereologica·Ngoc Quan PhanSonja Ständer
Oct 30, 2013·The Journal of Investigative Dermatology·Roderick J HayMohsen Naghavi
Oct 27, 2016·Neuroscience·Mélanie KremerMichel Barrot
Oct 4, 2016·The New England Journal of Medicine·Eric L SimpsonUNKNOWN SOLO 1 and SOLO 2 Investigators
Oct 19, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hiromitsu KumadaHidetomo Nakamoto
Jan 31, 2017·The Journal of Allergy and Clinical Immunology·Tomoki FukuyamaWolfgang Bäumer
May 4, 2017·Drugs·Manuel P Pereira, Sonja Ständer
Dec 19, 2017·American Journal of Nephrology·Vandana S MathurUNKNOWN TR02 Study Investigators
Jan 18, 2018·Allergy·T ZuberbierUNKNOWN Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI,
Jan 26, 2018·The Journal of Allergy and Clinical Immunology·Işın Sinem Bağci, Thomas Ruzicka
Jun 29, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·M AugustinN Zander
Nov 15, 2018·Expert Opinion on Investigational Drugs·Manuel P Pereira, Sonja Ständer
Apr 2, 2019·Acta Dermato-venereologica·Elke WeisshaarSonja Ständer
Apr 25, 2019·The British Journal of Dermatology·S Ständer, G Yosipovitch
Jun 25, 2019·Acta Dermato-venereologica·Zaid Z AlmustafaMartin Metz
Jul 17, 2019·Experimental Dermatology·Martin Metz
Aug 28, 2019·Experimental Dermatology·Andreas E Kremer
Jan 16, 2020·Acta Dermato-venereologica·Emilie Fowler, Gil Yosipovitch
Feb 1, 2020·Expert Opinion on Biological Therapy·Jianni Wu, Emma Guttman-Yassky
Feb 3, 2020·Journal of the American Academy of Dermatology·David M PariserMary C Spellman
Feb 20, 2020·The New England Journal of Medicine·Sonja StänderChristophe Piketty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
Martin Metz, Manuel P Pereira
Expert Opinion on Investigational Drugs
Heike BeneckeSonja Ständer
Expert Opinion on Pharmacotherapy
Manuel P Pereira, Sonja Ständer
Expert Opinion on Investigational Drugs
Manuel P Pereira, Sonja Ständer
© 2021 Meta ULC. All rights reserved